Clinical Scorecard: Peer-to-Peer: Ivan Damjanov Interviews Syed Ali

At a Glance

Key Highlights

• Syed Ali is a globally recognized cytopathologist and educator with extensive contributions including the Bethesda System for Reporting Thyroid Cytopathology.
• Cytopathology integrates traditional morphology with molecular markers and AI technologies to enhance diagnostic precision and personalized treatment.
• Thyroid cytopathology remains a clinically relevant and challenging subspecialty with significant impact on patient management.

Guideline-Based Recommendations

Diagnosis

• Use cytomorphology as the cornerstone for cytologic diagnosis.
• Incorporate molecular testing on cytologic samples to guide personalized medicine and targeted therapies.
• Apply HPV genotyping in cervical cancer screening to complement or reduce reliance on traditional PAP tests.

Management

• Engage cytopathologists in multidisciplinary collaboration for patient management decisions.
• Utilize standardized reporting systems such as the Bethesda System for thyroid cytopathology.
• Adopt emerging technologies including automated screening and AI-assisted evaluation to improve diagnostic workflows.

Monitoring & Follow-up

• Perform quality assurance and quality control activities regularly within cytopathology laboratories.
• Monitor evolving molecular classifications of tumors to update reporting and diagnostic criteria.
• Track performance and integration of digital pathology and AI tools in routine practice.

Risks

• Complexity of FNA cases may increase with molecular testing, requiring advanced interpretative skills.
• Potential for decreased sensitivity if relying solely on traditional PAP tests without adjunct molecular screening.
• Challenges in adapting to new technologies and ensuring accuracy in AI-assisted diagnostics.

Patient & Prescribing Data

Patients undergoing cytopathologic evaluation including thyroid FNAs and cervical cancer screening

Molecular testing on cytologic samples informs personalized and targeted therapies, enhancing clinical decision-making.

Clinical Best Practices

• Maintain expertise in both cytomorphology and molecular ancillary testing for comprehensive diagnosis.
• Foster mentorship and collaboration among pathology colleagues to address complex cases.
• Continuously update knowledge on molecular classifications and technological advancements in cytopathology.
• Utilize standardized reporting frameworks to ensure clarity and consistency in diagnostic communication.

References

• The Bethesda System for Reporting Thyroid Cytopathology
• American Society of Cytopathology
• Johns Hopkins Pathology